Study Evaluating MOA-728 Administered in Healthy Men
This study has been withdrawn prior to enrollment.
Information provided by:
First received: January 25, 2007
Last updated: July 22, 2011
Last verified: July 2011
Absorption, distribution, metabolism, and excretion (ADME) study with 14C in healthy young men.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||An Open-Label, Single-Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered [14C]MOA-728 in Healthy Men|
Further study details as provided by Salix Pharmaceuticals:
Contacts and Locations